Clovis Oncology (CLVS) Adds to Intra-Day Gains on Rampant M&A Chatter

September 20, 2016 4:56 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Clovis Oncology (NASDAQ: CLVS) adds to intra-day rumor-fueled gains after-hours. Shares are up 6% after-hours after gaining 12.7% intra-day on increased takeover chatter.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment